Japanese Drugmaker Rapped for Cleaning Violations

Drug Industry Daily
A A
The FDA hit API drugmaker Alps Pharmaceutical of Gifu, Japan with a Form 483 for contamination, inadequate written procedures for cleaning and other violations.

To View This Article:

Login

Subscribe To Drug Industry Daily